Dishman Pharmaceuticals allots 1139650 equity shares upon conversion of FCCB

Dishman Pharmaceuticals & Chemicals Ltd has announced that the Board of Directors of the Company on January 25, 2008, has allotted 11,39,650 equity shares of Rs 2/- each of the Company at a premium of Rs 170/- per equity share upon exercise of option of conversion by the FCCB holders for conversion of 0.50% Foreign Currency Convertible Bonds (FCCB) of the principal amount of US$ 4,500,000, into the equity shares of the Company.

Consequently, the paid-up equity share capital of the Company has increased from 77531440 equity shares of Rs 2/- each to 78671090 equity shares of Rs 2/- each.

Source : Equity Bulls

Keywords